Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED.. 33
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY USED FOR THE STUDY
1.5             MAJOR MARKET STAKEHOLDERS
1.6             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・       FIGURE 1.................................................. RESEARCH DESIGN.. 36
2.1.1              SECONDARY DATA
2.1.1.1            SECONDARY SOURCES
2.1.2              PRIMARY DATA
・       FIGURE 2................. BREAKDOWN OF PRIMARIES: POINT-OF-CARE DIAGNOSTICS MARKET
2.2             MARKET ESTIMATION METHODOLOGY
・       FIGURE 3......... RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1              REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2              END USER-BASED MARKET ESTIMATION
・       FIGURE 4. MARKET SIZE ESTIMATION: POINT-OF-CARE DIAGNOSTICS MARKET
2.2.3              PRIMARY RESEARCH VALIDATION
2.3             DATA TRIANGULATION
・       FIGURE 5.......................... DATA TRIANGULATION METHODOLOGY
2.4             RESEARCH ASSUMPTIONS
2.5             RESEARCH LIMITATIONS

3.... EXECUTIVE SUMMARY

・       FIGURE 6...... POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION)
・       FIGURE 7.... POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM,
2020 VS. 2025 (USD MILLION)
・       FIGURE 8........ POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE,
2020 VS. 2025 (USD MILLION)
・       FIGURE 9..... POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION)
・       FIGURE 10....... GEOGRAPHICAL SNAPSHOT OF THE POINT-OF-CARE DIAGNOSTICS MARKET

4.... PREMIUM INSIGHTS

4.1             POINT-OF-CARE DIAGNOSTICS MARKET OVERVIEW
・       FIGURE 11 INCREASINGLY SUPPORTIVE GOVERNMENT POLICIES AND RISING PREVALENCE OF TARGET DISEASES ARE DRIVING THE MARKET GROWTH
4.2             POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2020
・       FIGURE 12. OTC TESTING PRODUCTS DOMINATE THE POINT-OF-CARE DIAGNOSTICS MARKET IN 2020
4.3             ASIA PACIFIC: POINT-OF-CARE DIAGNOSTICS MARKET
・       FIGURE 13.... HOME CARE SETTINGS WERE THE LARGEST END-USER SEGMENT IN THE APAC POC DIAGNOSTICS MARKET IN 2020
4.4             POINT-OF-CARE DIAGNOSTICS MARKET, BY REGION
・       FIGURE 14... APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2020–2025)

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 15......... POINT-OF-CARE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1              DRIVERS
5.2.1.1            HIGH PREVALENCE OF INFECTIOUS DISEASES
5.2.1.2            INCREASING INCIDENCE OF TARGET CONDITIONS
5.2.1.3            SUPPORTIVE GOVERNMENT POLICIES
5.2.1.4            DEARTH OF SKILLED LABORATORY TECHNICIANS
5.2.1.5            RISING NUMBER OF CLIA-WAIVED POC TESTS
・       TABLE 1...................... RECENT WAIVERS FOR MARKET PRODUCTS
5.2.2              RESTRAINTS
5.2.2.1            PRICING PRESSURE OWING TO REIMBURSEMENT CUTS AND BUDGET CONSTRAINTS
5.2.2.2            STRINGENT REGULATORY POLICIES
5.2.3              OPPORTUNITIES
5.2.3.1            EMERGING MARKETS
5.2.3.2            HEALTHCARE DECENTRALIZATION
5.2.3.3            INCREASING PROVIDER AWARENESS ABOUT NOVEL TECHNOLOGIES
5.2.3.4            POC TESTS WITH MULTIPLEXING CAPABILITIES
5.2.3.5            GROWING INVESTMENTS AND FUNDING FOR PRODUCT DEVELOPMENT
5.2.4              CHALLENGES
5.2.4.1            LACK OF ALIGNMENT WITH DEFINITIVE CENTRAL LAB METHODS
5.2.4.2            INADEQUATE ADOPTION OF POC DEVICES IN PROFESSIONAL SETTINGS
5.2.4.3            RELUCTANCE TO CHANGE EXISTING DIAGNOSTIC PRACTICES
5.2.4.4            PREMIUM PRICING OF NOVEL PLATFORMS
5.3             TECHNOLOGY ANALYSIS: EMERGING POINT-OF-CARE APPLICATIONS
5.3.1              SEPSIS BIOMARKERS.. 60
5.3.2              STROKE/CARDIAC MARKERS
5.3.3              THYROID TESTING.. 62
5.3.4              DNA TESTING
5.3.5              ENDOCRINE TESTING.. 62
5.3.6              RESPIRATORY DIAGNOSTICS
5.4             GLOBAL REGULATORY LANDSCAPE
5.5             INDUSTRY TRENDS RELATED TO COVID-19
5.6             VALUE CHAIN ANALYSIS
・       FIGURE 16........ VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING
THE REGULATION AND DISTRIBUTION STAGES
5.7             PRICING TREND ANALYSIS
・       TABLE 2............... AVERAGE PRICE OF GLUCOSE MONITORING AND CARDIOMETABOLIC MONITORING PRODUCTS, BY COUNTRY, 2019 (USD)
・       TABLE 3............. AVERAGE PRICE OF INFECTIOUS DISEASE TESTING PRODUCTS, BY COUNTRY, 2019 (USD)
・       TABLE 4........... AVERAGE PRICE OF OTHER POINT-OF-CARE TESTING PRODUCTS,
BY COUNTRY, 2019 (USD)
5.8             ECOSYSTEM COVERAGE: PARENT MARKET (IN VITRO DIAGNOSTICS)
5.9             USE CASES: POINT-OF-CARE DIAGNOSTICS MARKET
5.9.1              REVENUE OPPORTUNITIES: IVD ASSAY DEVELOPMENT SERVICES
5.9.2              REVENUE OPPORTUNITIES: IVD CONTRACT RESEARCH SERVICES

6.... POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT

6.1             INTRODUCTION
・       TABLE 5........ POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
6.2             GLUCOSE MONITORING PRODUCTS
・       TABLE 6........ POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 7........ POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 8........ POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 9........ POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 10...... POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.2.1              STRIPS
6.2.1.1            STRIPS MAKE BLOOD GLUCOSE TESTING EASY AND HASSLE-FREE
・       TABLE 11....... GLUCOSE MONITORING STRIPS MARKET, BY REGION,
2018–2025 (USD MILLION)
6.2.2              METERS
6.2.2.1            BLOOD GLUCOSE METERS ARE EXTREMELY HELPFUL IN THE MONITORING OF BLOOD GLUCOSE LEVELS AND ADJUSTING THERAPEUTIC REGIMENS
・       TABLE 12...... GLUCOSE MONITORING METERS MARKET, BY REGION,
2018–2025 (USD MILLION)
6.2.3              LANCETS & LANCING DEVICES
6.2.3.1            LANCETS & LANCING DEVICES SEGMENT TO GROW AT THE LOWEST CAGR IN THE GLUCOSE MONITORING PRODUCTS MARKET
・       TABLE 13...... GLUCOSE MONITORING LANCETS & LANCING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3             CARDIOMETABOLIC MONITORING PRODUCTS
・       TABLE 14................... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 15................... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 16................... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY MODE OF PURCHASE,
2018–2025 (USD MILLION)
・       TABLE 17................... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 18................... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.3.1              CARDIAC MARKER TESTING PRODUCTS
6.3.1.1            RISING GOVERNMENT INITIATIVES FOR CVD RESEARCH WILL CONTRIBUTE TO MARKET GROWTH
・       TABLE 19....... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIAC MARKER TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 20....... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIAC MARKER TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 21....... POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIAC MARKER TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.3.2              BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
6.3.2.1            TECHNOLOGICAL ADVANCEMENTS IN BLOOD GAS/ELECTROLYTE PRODUCTS WILL DRIVE THE GROWTH OF THIS MARKET SEGMENT
・       TABLE 22......... POINT-OF-CARE DIAGNOSTICS MARKET FOR BLOOD GAS/ELECTROLYTE TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 23......... POINT-OF-CARE DIAGNOSTICS MARKET FOR BLOOD GAS/ELECTROLYTE TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 24......... POINT-OF-CARE DIAGNOSTICS MARKET FOR BLOOD GAS/ELECTROLYTE TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.3.3              HBA1C TESTING PRODUCTS
6.3.3.1            GOVERNMENT INITIATIVES ARE PROMOTING THE REGULAR USE OF HBA1C TESTING
・       TABLE 25......... POINT-OF-CARE DIAGNOSTICS MARKET FOR HBA1C TESTING PRODUCTS,
BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 26......... POINT-OF-CARE DIAGNOSTICS MARKET FOR HBA1C TESTING PRODUCTS,
BY END USER, 2018–2025 (USD MILLION)
・       TABLE 27......... POINT-OF-CARE DIAGNOSTICS MARKET FOR HBA1C TESTING PRODUCTS,
BY REGION, 2018–2025 (USD MILLION)
6.4             INFECTIOUS DISEASE TESTING PRODUCTS
・       TABLE 28... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 29... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 30... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 31... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 32... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.4.1              HIV TESTING PRODUCTS
6.4.1.1            RISING PREVALENCE OF HIV TO DRIVE MARKET GROWTH
・       TABLE 33... POINT-OF-CARE DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS,
BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 34... POINT-OF-CARE DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS,
BY END USER, 2018–2025 (USD MILLION)
・       TABLE 35... POINT-OF-CARE DIAGNOSTICS MARKET FOR HIV TESTING PRODUCTS,
BY REGION, 2018–2025 (USD MILLION)
6.4.2              RESPIRATORY INFECTION TESTING PRODUCTS
6.4.2.1            POCT PRODUCTS FOR THE DIAGNOSIS OF RESPIRATORY INFECTIONS OFFER LOWER SENSITIVITY AS COMPARED TO OTHER TESTS
・       TABLE 36 POINT-OF-CARE DIAGNOSTICS MARKET FOR RESPIRATORY INFECTION TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 37 POINT-OF-CARE DIAGNOSTICS MARKET FOR RESPIRATORY INFECTION TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 38 POINT-OF-CARE DIAGNOSTICS MARKET FOR RESPIRATORY INFECTION TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.4.3              HEPATITIS C TESTING PRODUCTS
6.4.3.1            CENTRAL AND EAST ASIA ARE AMONG THE HIGHLY AFFECTED REGIONS WITH HEPATITIS C
・       TABLE 39... POINT-OF-CARE DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 40... POINT-OF-CARE DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION). 88
・       TABLE 41... POINT-OF-CARE DIAGNOSTICS MARKET FOR HEPATITIS C TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.4.4              HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS
6.4.4.1            RISING PREVALENCE OF HAIS IS THE KEY FACTOR DRIVING MARKET GROWTH
・       TABLE 42 POINT-OF-CARE DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY MODE OF PURCHASE,
2018–2025 (USD MILLION)
・       TABLE 43 POINT-OF-CARE DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 44 POINT-OF-CARE DIAGNOSTICS MARKET FOR HEALTHCARE-ASSOCIATED INFECTION TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.4.5              INFLUENZA TESTING PRODUCTS
6.4.5.1            RISING INFLUENZA PREVALENCE HAS DRIVEN THE DEMAND FOR INFLUENZA TESTING PRODUCTS
・       TABLE 45.... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 46.... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 47.... POINT-OF-CARE DIAGNOSTICS MARKET FOR INFLUENZA TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.4.6              TROPICAL DISEASE TESTING PRODUCTS
6.4.6.1            INCREASING GOVERNMENT FUNDING FOR THE USE OF POC IN TROPICAL DISEASE TESTING WILL SUPPORT MARKET GROWTH
・       TABLE 48...... POINT-OF-CARE DIAGNOSTICS MARKET FOR TROPICAL DISEASE TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 49...... POINT-OF-CARE DIAGNOSTICS MARKET FOR TROPICAL DISEASE TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 50...... POINT-OF-CARE DIAGNOSTICS MARKET FOR TROPICAL DISEASE TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.4.7              SEXUALLY TRANSMITTED DISEASE TESTING PRODUCTS
6.4.7.1            PRIVACY AND CONFIDENTIALITY ISSUES ARE THE KEY FACTORS LEADING TO THE ADOPTION OF POC STD TESTING PRODUCTS
・       TABLE 51.. POINT-OF-CARE DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS,
BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 52.. POINT-OF-CARE DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS,
BY END USER, 2018–2025 (USD MILLION)
・       TABLE 53.. POINT-OF-CARE DIAGNOSTICS MARKET FOR STD TESTING PRODUCTS,
BY REGION, 2018–2025 (USD MILLION)
6.4.8              OTHER INFECTIOUS DISEASE TESTING PRODUCTS
・       TABLE 54.......... POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 55.......... POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 56.......... POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASE TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.5             COAGULATION MONITORING PRODUCTS
・       TABLE 57 POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 58 POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 59 POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 60 POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 61 POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY REGION, 2018–2025 (USD MILLION). 98
6.5.1              PT/INR TESTING PRODUCTS
6.5.1.1            PT/INR IS ONE OF THE MOST COMMONLY USED COAGULATION MONITORING METHODS
・       TABLE 62......... POINT-OF-CARE DIAGNOSTICS MARKET FOR PT/INR TESTING PRODUCTS,
BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 63......... POINT-OF-CARE DIAGNOSTICS MARKET FOR PT/INR TESTING PRODUCTS,
BY END USER, 2018–2025 (USD MILLION)
・       TABLE 64......... POINT-OF-CARE DIAGNOSTICS MARKET FOR PT/INR TESTING PRODUCTS,
BY REGION, 2018–2025 (USD MILLION)
6.5.2              ACT/APTT TESTING PRODUCTS
6.5.2.1            RISING NUMBER OF PATIENTS UNDERGOING ANGIOPLASTY AND DIALYSIS GLOBALLY TO SUPPORT MARKET GROWTH
・       TABLE 65...... POINT-OF-CARE DIAGNOSTICS MARKET FOR ACT/APTT TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 66...... POINT-OF-CARE DIAGNOSTICS MARKET FOR ACT/APTT TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 67...... POINT-OF-CARE DIAGNOSTICS MARKET FOR ACT/APTT TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.6             PREGNANCY & FERTILITY TESTING PRODUCTS
・       TABLE 68 POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 69 POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 70 POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 71 POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 72 POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.6.1              PREGNANCY TESTING PRODUCTS
6.6.1.1            RISING INCLINATION TOWARD HOME TESTING TO SUPPORT MARKET GROWTH.. 103
・       TABLE 73.. POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 74.. POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION). 103
・       TABLE 75.. POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.6.2              FERTILITY TESTING PRODUCTS
6.6.2.1            INCREASING AWARENESS OF FERTILITY TESTING TO DRIVE MARKET GROWTH
・       TABLE 76...... POINT-OF-CARE DIAGNOSTICS MARKET FOR FERTILITY TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 77...... POINT-OF-CARE DIAGNOSTICS MARKET FOR FERTILITY TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 78...... POINT-OF-CARE DIAGNOSTICS MARKET FOR FERTILITY TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.7             TUMOR/CANCER MARKER TESTING PRODUCTS
6.7.1              INCREASING INVESTMENTS FOR RESEARCH RELATED TO POC CANCER TESTING ARE DRIVING MARKET GROWTH.. 106
・       TABLE 79................... POINT-OF-CARE DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 80................... POINT-OF-CARE DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 81................... POINT-OF-CARE DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 82................... POINT-OF-CARE DIAGNOSTICS MARKET FOR TUMOR/CANCER MARKER TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.8             URINALYSIS TESTING PRODUCTS
6.8.1              RISING PREVALENCE OF URINARY TRACT INFECTIONS IS DRIVING MARKET GROWTH
・       TABLE 83... POINT-OF-CARE DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION). 108
・       TABLE 84... POINT-OF-CARE DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 85... POINT-OF-CARE DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION). 108
・       TABLE 86... POINT-OF-CARE DIAGNOSTICS MARKET FOR URINALYSIS TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.9             CHOLESTEROL TESTING PRODUCTS
6.9.1              RISING OBESITY LEVELS & CARDIOVASCULAR DISORDER INCIDENCE ARE THE KEY FACTORS SUPPORTING MARKET GROWTH
・       TABLE 87 POINT-OF-CARE DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION). 109
・       TABLE 88 POINT-OF-CARE DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 89 POINT-OF-CARE DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION). 110
・       TABLE 90 POINT-OF-CARE DIAGNOSTICS MARKET FOR CHOLESTEROL TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.10          HEMATOLOGY TESTING PRODUCTS
6.10.1            PREFERENCE FOR LABORATORY-BASED TESTS AMONG USERS WILL IMPEDE MARKET GROWTH
・       TABLE 91. POINT-OF-CARE DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION). 111
・       TABLE 92. POINT-OF-CARE DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 93. POINT-OF-CARE DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION). 112
・       TABLE 94. POINT-OF-CARE DIAGNOSTICS MARKET FOR HEMATOLOGY TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.11          DRUGS-OF-ABUSE TESTING PRODUCTS
6.11.1            RISING CONSUMPTION OF ILLICIT DRUGS HAS BOOSTED DEMAND FOR TESTING
・       TABLE 95... POINT-OF-CARE DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION). 113
・       TABLE 96... POINT-OF-CARE DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 97... POINT-OF-CARE DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION). 113
・       TABLE 98... POINT-OF-CARE DIAGNOSTICS MARKET FOR DRUGS-OF-ABUSE TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.12          FECAL OCCULT TESTING PRODUCTS
6.12.1            LACK OF PROPER TRAINING IN THE USE OF FECAL OCCULT TESTING
TO HAMPER MARKET ADOPTION
・       TABLE 99 POINT-OF-CARE DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY PLATFORM, 2018–2025 (USD MILLION). 114
・       TABLE 100........ POINT-OF-CARE DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 101........ POINT-OF-CARE DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY END USER, 2018–2025 (USD MILLION)
・       TABLE 102........ POINT-OF-CARE DIAGNOSTICS MARKET FOR FECAL OCCULT TESTING PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
6.13          OTHER POC PRODUCTS
・       TABLE 103.. POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER POC PRODUCTS,
BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 104........ POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER PRODUCTS,
BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 105.. POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER POC PRODUCTS,
BY END USER, 2018–2025 (USD MILLION)
・       TABLE 106.. POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER POC PRODUCTS,
BY REGION, 2018–2025 (USD MILLION)

7.... POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM

7.1             INTRODUCTION
・       TABLE 107... POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM,
2018–2025 (USD MILLION)
7.2             LATERAL FLOW ASSAYS
7.2.1              TECHNOLOGICAL ADVANCEMENTS AND INCREASING ADOPTION OF LFA ARE SUPPORTING MARKET GROWTH.. 119
・       TABLE 108..... POINT-OF-CARE DIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS,
BY REGION, 2018–2025 (USD MILLION)
7.3             IMMUNOASSAYS
7.3.1              RISING INCIDENCE OF CANCER AND GROWING AWARENESS ABOUT IMMUNOASSAY PLATFORMS TO SUPPORT MARKET GROWTH
・       TABLE 109................. POINT-OF-CARE DIAGNOSTICS MARKET FOR IMMUNOASSAYS, BY REGION, 2018–2025 (USD MILLION)
7.4             MICROFLUIDICS
7.4.1              MICROFLUIDICS IS AN EMERGING PLATFORM IN
THE POC DIAGNOSTICS MARKET
・       TABLE 110................. POINT-OF-CARE DIAGNOSTICS MARKET FOR MICROFLUIDICS, BY REGION, 2018–2025 (USD MILLION)
7.5             DIPSTICKS
7.5.1              DIPSTICKS HELP IN THE ROUTINE ANALYSIS OF SEVERAL MEDICAL CONDITIONS
・       TABLE 111.. POINT-OF-CARE DIAGNOSTICS MARKET FOR DIPSTICKS, BY REGION,
2018–2025 (USD MILLION)
7.6             MOLECULAR DIAGNOSTICS
7.6.1              INCREASING INITIATIVES BY MARKET PLAYERS FOR DEVELOPING POC MOLECULAR DIAGNOSTIC PRODUCTS TO DRIVE MARKET GROWTH
・       TABLE 112 POINT-OF-CARE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS,
BY REGION, 2018–2025 (USD MILLION)

8.... POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE

8.1             INTRODUCTION
・       TABLE 113...... POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE,
2018–2025 (USD MILLION)
8.2             OTC TESTING PRODUCTS
8.2.1              RISING FOCUS ON HOME CARE IS EXPECTED TO BOOST THE DEMAND FOR OTC TESTING IN THE COMING YEARS
・       TABLE 114..... OTC POINT-OF-CARE TESTING PRODUCTS MARKET, BY REGION,
2018–2025 (USD MILLION)
8.3             PRESCRIPTION-BASED TESTING PRODUCTS
8.3.1              GROWING PREVALENCE OF LIFESTYLE DISEASES AND FAVORABLE REIMBURSEMENT HAVE DRIVEN MARKET GROWTH
・       TABLE 115............ PRESCRIPTION-BASED POINT-OF-CARE TESTING PRODUCTS MARKET,
BY REGION, 2018–2025 (USD MILLION)

9.... POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER

9.1             INTRODUCTION
・       TABLE 116.... POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION)
9.2             OUTPATIENT & AMBULATORY CARE FACILITIES
9.2.1              RAPID RESULT GENERATION AND AVAILABILITY OF IMMEDIATE PATIENT CARE ARE THE MAJOR FACTORS DRIVING MARKET GROWTH
・       TABLE 117. POINT-OF-CARE DIAGNOSTICS MARKET FOR OUTPATIENT & AMBULATORY CARE FACILITIES, BY REGION, 2018–2025 (USD MILLION)
9.3             HOSPITALS & CRITICAL CARE CENTERS
9.3.1              HOSPITALS ARE AMONG THE LARGEST END USERS OF POC DIAGNOSTICS
・       TABLE 118 POINT-OF-CARE DIAGNOSTICS MARKET FOR HOSPITALS & CRITICAL CARE CENTERS, BY REGION, 2018–2025 (USD MILLION)
9.4             HOME CARE SETTINGS
9.4.1              INCREASING INCLINATION TOWARD HOME HEALTHCARE IS DRIVING THE GROWTH OF THIS END-USER SEGMENT
・       TABLE 119. POINT-OF-CARE DIAGNOSTICS MARKET FOR HOME CARE SETTINGS,
BY REGION, 2018–2025 (USD MILLION)
9.5             OTHER END USERS
・       TABLE 120.. POINT-OF-CARE DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)

10.. POINT-OF-CARE DIAGNOSTICS MARKET, BY REGION

10.1          INTRODUCTION
・       TABLE 121....... POINT-OF-CARE DIAGNOSTICS MARKET, BY REGION,
2018–2025 (USD MILLION)
10.2          NORTH AMERICA
・       FIGURE 17 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET SNAPSHOT
・       TABLE 122 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 123 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
・       TABLE 124 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 125 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 126 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 127 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 128 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 129 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 130 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 131 NORTH AMERICA: POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1            US
10.2.1.1          THE US DOMINATES THE NORTH AMERICAN MARKET FOR POC DIAGNOSTICS.. 140
・       TABLE 132 US: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.2.2            CANADA
10.2.2.1          RISING GOVERNMENT INITIATIVES TO SUPPORT THE GROWTH OF THE POC DIAGNOSTICS MARKET IN CANADA
・       TABLE 133...... CANADA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.3          EUROPE
・       TABLE 134...... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 135...... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 136..... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 137..... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 138..... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 139..... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 140..... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 141...... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM,
2018–2025 (USD MILLION)
・       TABLE 142...... EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 143 EUROPE: POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION)
10.3.1            GERMANY
10.3.1.1          GERMANY ACCOUNTS FOR THE LARGEST SHARE OF THE EUROPEAN MARKET
・       TABLE 144.... GERMANY: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.3.2            FRANCE
10.3.2.1          GROWING PUBLIC-PRIVATE COLLABORATIONS FOR PRODUCT DEVELOPMENT TO DRIVE MARKET GROWTH
・       TABLE 145....... FRANCE: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.3.3            UK
10.3.3.1          GROWING AWARENESS OF THE BENEFITS OFFERED BY POC DIAGNOSTICS TO SUPPORT MARKET GROWTH IN THE UK
・       TABLE 146 UK: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.3.4            ITALY
10.3.4.1          RISING PREVALENCE OF CHRONIC DISEASES IN ITALY TO DRIVE THE DEMAND FOR POINT-OF-CARE DIAGNOSTICS
・       TABLE 147.......... ITALY: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.3.5            SPAIN
10.3.5.1          INCREASING FUNDING FOR RESEARCH IN SPAIN TO BOOST MARKET GROWTH
・       TABLE 148......... SPAIN: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.3.6            REST OF EUROPE
・       TABLE 149............ ROE: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.4          ASIA PACIFIC
・       FIGURE 18 APAC: POINT-OF-CARE DIAGNOSTICS MARKET SNAPSHOT
・       TABLE 150.......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 151.......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 152......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 153......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 154......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 155......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 156......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 157.......... APAC: POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM,
2018–2025 (USD MILLION)
・       TABLE 158. APAC: POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 159.... APAC: POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION)
10.4.1            JAPAN
10.4.1.1          JAPAN TO DOMINATE THE APAC POC DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
・       TABLE 160......... JAPAN: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.4.2            CHINA
10.4.2.1          RISING INVESTMENTS BY MARKET PLAYERS AND THE CHINESE GOVERNMENT TO DRIVE MARKET GROWTH
・       TABLE 161......... CHINA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.4.3            INDIA
10.4.3.1          HIGH BURDEN OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
・       TABLE 162.......... INDIA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.4.4            AUSTRALIA
10.4.4.1          HIGH BURDEN OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
・       TABLE 163... AUSTRALIA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.4.5            SOUTH KOREA
10.4.5.1          INCREASED FUNDING AND PRODUCT DEVELOPMENT TO PROPEL MARKET GROWTH
・       TABLE 164.. SOUTH KOREA: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
10.4.6            REST OF ASIA PACIFIC
・       TABLE 165...... ROAPAC: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.5          LATIN AMERICA
・       TABLE 166........ LATAM: POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 167........ LATAM: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
・       TABLE 168....... LATAM: POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 169....... LATAM: POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 170....... LATAM: POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 171....... LATAM: POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 172....... LATAM: POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 173........ LATAM: POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM,
2018–2025 (USD MILLION)
・       TABLE 174 LATAM: POINT-OF-CARE DIAGNOSTICS MARKET, BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 175.. LATAM: POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION)
10.5.1            BRAZIL
10.5.1.1          RISING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH IN BRAZIL
・       TABLE 176........ BRAZIL: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.5.2            MEXICO
10.5.2.1          RISING PREVALENCE OF DIABETES AND CANCER TO SUPPORT MARKET GROWTH IN MEXICO
・       TABLE 177....... MEXICO: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.5.3            REST OF LATIN AMERICA
・       TABLE 178..... ROLATAM: POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT,
2018–2025 (USD MILLION)
10.6          MIDDLE EAST & AFRICA
10.6.1            RISING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH IN THE MEA
・       TABLE 179... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET,
BY PRODUCT, 2018–2025 (USD MILLION)
・       TABLE 180... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR GLUCOSE MONITORING PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 181... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR CARDIOMETABOLIC MONITORING PRODUCTS, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 182... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE TESTING PRODUCTS, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 183... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR COAGULATION MONITORING PRODUCTS, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 184... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET FOR PREGNANCY & FERTILITY TESTING PRODUCTS, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 185... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET,
BY PLATFORM, 2018–2025 (USD MILLION)
・       TABLE 186... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET,
BY MODE OF PURCHASE, 2018–2025 (USD MILLION)
・       TABLE 187... MIDDLE EAST & AFRICA: POINT-OF-CARE DIAGNOSTICS MARKET,
BY END USER, 2018–2025 (USD MILLION)

11.. COMPETITIVE LANDSCAPE

11.1          OVERVIEW
・       FIGURE 19........................ KEY DEVELOPMENTS IN THE POINT-OF-
CARE DIAGNOSTICS MARKET (2017–2020)
11.2          MARKET SHARE ANALYSIS (2019)
・       FIGURE 20.... ROCHE DIAGNOSTICS HELD THE LEADING POSITION IN THE MARKET IN 2019
11.3          COMPETITIVE SCENARIO (2016–2020)
・       FIGURE 21.... STRATEGIC OVERVIEW: MAJOR PLAYERS (2016–2020)
11.3.1            KEY PRODUCT LAUNCHES & PRODUCT APPROVALS (2016–2020)
11.3.2            KEY ACQUISITIONS (2016–2020)
11.3.3            KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2016–2020)
11.4          COMPETITIVE LEADERSHIP MAPPING: MAJOR GLOBAL PLAYERS (AS OF 2019)
11.4.1            STARS
11.4.2            EMERGING LEADERS
11.4.3            PERVASIVE PLAYERS
11.4.4            PARTICIPANTS
・       FIGURE 22.... POINT-OF-CARE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 (MAJOR GLOBAL PLAYERS)
11.5          COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS
(AS OF 2019)
11.5.1            PROGRESSIVE COMPANIES
11.5.2            STARTING BLOCKS.. 185
11.5.3            RESPONSIVE COMPANIES
11.5.4            DYNAMIC COMPANIES.. 185

12.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
12.1          ROCHE DIAGNOSTICS
・       FIGURE 24................ ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
12.2          SIEMENS HEALTHINEERS
・       FIGURE 25............ SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
12.3          DANAHER CORPORATION
・       FIGURE 26........... DANAHER CORPORATION: COMPANY SNAPSHOT
12.4          BECTON, DICKINSON AND COMPANY
・       FIGURE 27............ BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
12.5          ABBOTT LABORATORIES
・       FIGURE 28............. ABBOTT LABORATORIES: COMPANY SNAPSHOT
12.6          QUIDEL CORPORATION
・       FIGURE 29.............. QUIDEL CORPORATION: COMPANY SNAPSHOT
12.7          CHEMBIO DIAGNOSTICS
・       FIGURE 30............. CHEMBIO DIAGNOSTICS: COMPANY SNAPSHOT
12.8          JOHNSON & JOHNSON
・       FIGURE 31............... JOHNSON & JOHNSON: COMPANY SNAPSHOT
12.9          EKF DIAGNOSTICS
・       FIGURE 32.................... EKF DIAGNOSTICS: COMPANY SNAPSHOT
12.10        TRINITY BIOTECH
・       FIGURE 33...................... TRINITY BIOTECH: COMPANY SNAPSHOT
12.11        ACCUBIOTECH
12.12        INSTRUMENTATION LABORATORY (A WERFEN COMPANY)
12.13        NOVA BIOMEDICAL
12.14        PTS DIAGNOSTICS
12.15        SEKISUI DIAGNOSTICS
12.16        FLUXERGY
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

13.. APPENDIX

当レポートのプレスリリースは発行されておりません。